Copeptin During a Standardized Psychological Stress Test
NCT01866137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2014-09-09
Summary
The aim of the PsyCo Study is to determine whether psychological Stress has an influence on copeptin levels.
Conditions
- Stress
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Mirjam Christ-Crain, Prof.Dr.med.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2013-06-30
- Completion
- 2014-02-28
Countries
- Switzerland
Study Locations
More Related Trials
-
A Study On The Effect Of Vitano® On Physiological And Psychological Responses To Psychological Stress
NCT01411709 ·Status: COMPLETED ·Phase: PHASE4
-
ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation
NCT04380909 ·Status: COMPLETED ·Phase: NA
-
Cognitive and Biological Responses in Stress
NCT05026333 ·Status: COMPLETED ·Phase: NA
-
Effects of Oxytocin on Behavior and Physiology in a Psychotherapy Setting
NCT01081249 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Markers of Panic and Generalized Anxiety Disorder
NCT06071819 ·Status: COMPLETED
-
Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety
NCT05562739 ·Status: COMPLETED ·Phase: NA
-
Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder
NCT04071600 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
CO2 Inhalation and Risk for Panic Disorder
NCT00930657 ·Status: TERMINATED
-
The Effects of Propranolol and Hydrocortisone on Military-Relevant Performance Outcomes
NCT06982183 ·Status: RECRUITING ·Phase: PHASE4
-
Inter-Brain Synchrony in Psychotherapy for Test Anxiety
NCT05336734 ·Status: COMPLETED ·Phase: NA
-
Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers
NCT00748956 ·Status: COMPLETED ·Phase: PHASE2
-
Scaling-up Psychological Interventions With Syrian Refugees in Switzerland (STRENGTHS_CH): RCT
NCT04574466 ·Status: COMPLETED ·Phase: NA
-
Pain Processing in Anxiety and Depression
NCT00560196 ·Status: COMPLETED
-
LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
NCT03153579 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder
NCT01856530 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder
NCT01949753 ·Status: UNKNOWN ·Phase: PHASE2
-
Glucocorticoid Treatment for Social Phobia
NCT01574014 ·Status: TERMINATED ·Phase: PHASE2
-
Tutorial of Clinical Trial Registration
NCT03481452 ·Status: UNKNOWN ·Phase: NA
-
Impact of a Mobile Application (Pacifica) on Stress, Anxiety, and Depression
NCT03333707 ·Status: COMPLETED ·Phase: NA
-
COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes
NCT05119400 ·Status: TERMINATED
-
Oxytocin Administration in BDD and OCD
NCT02671266 ·Status: COMPLETED ·Phase: PHASE2
-
Expectation of Unpleasant Events in Anxiety Disorders
NCT00055224 ·Status: COMPLETED ·Phase: NA
-
Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study)
NCT00947570 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Panic Disorders Treatment
NCT01323556 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder
NCT00705380 ·Status: COMPLETED ·Phase: PHASE2